t(8;16) AML developed subsequent to breast cancer therapy

Hematology

Volumn 11, Issue 3, 2006, Pages 153-155

  Sahin, Feride Iffet ^a   YIlmaz, Zerrin ^a   Karakuş, Sema ^a   Boǧa, Salih ^a   Akçali, Zefer ^a   Demirhan, Beyhan ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Acute myeloid leukemia; Adjuvant therapy; Breast cancer; t(8; 16)

Indexed keywords

ANASTROZOLE; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; FLUOROURACIL; IDARUBICIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; BONE MARROW BIOPSY; BREAST BIOPSY; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER HORMONE THERAPY; CASE REPORT; CHROMOSOME ANALYSIS; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION 16; CHROMOSOME TRANSLOCATION 8; DRUG FEVER; FEMALE; HISTOPATHOLOGY; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; MAMMOGRAPHY; MASTECTOMY; PAGET NIPPLE DISEASE; PANCYTOPENIA; PRIORITY JOURNAL; PROGNOSIS; SOMNOLENCE; VAGINA BLEEDING;

ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CHEMOTHERAPY, ADJUVANT; CHROMOSOMES, HUMAN, PAIR 16; CHROMOSOMES, HUMAN, PAIR 8; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ESTROGENS; FATAL OUTCOME; FEMALE; FLUOROURACIL; HUMANS; IDARUBICIN; LEUKEMIA, MYELOMONOCYTIC, ACUTE; MASTECTOMY, MODIFIED RADICAL; MIDDLE AGED; NEOPLASMS, HORMONE-DEPENDENT; NEOPLASMS, MULTIPLE PRIMARY; NEOPLASMS, SECOND PRIMARY; NITRILES; RADIOTHERAPY, ADJUVANT; TRANSLOCATION, GENETIC; TRIAZOLES;

EID: 33748498474     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1080/10245330600775030     Document Type: Article

References (12)

1. Srivastava, A and Murari, M and Datta, NR. (2004) Early occurrence of acute myeloid leukemia following adjuvant radiotherapy and higher cumulative dose of cyclophosphamide in carcinoma breast Indian J Cancer, 41, pp. 178-180.
2. Kaplan, HG and Malmgren, JA and Atwood, M. (2004) Leukemia incidence following primary breast carcinoma treatment Cancer, 101, pp. 1529-1536.
3. Bernasconi, P and Orlandi, E and Cavigliano, P and Calatroni, S and Boni, M and Astori, C and Pagnucco, G and Giglio, S and Caresana, M and Lazzarino, M and Bernasconi, C. (2000) Translocation (8;16) in a patient with acute myelomonocytic leukemia, occurring after treatment with fludarabine for a low-grade non-Hodgkin's lymphoma Haematologica, 85, pp. 1087-1091.
4. Pérot C, Huret JL. t(8;16)(p11;p13). In: Atlas of genetics and cytogenetics in oncology and haematology [internet]. Updated December 1998. Available from http://www/infobiogen.fr/services/chromcancer/ Anomalies/t0816.html.
5. Verma, RS and Babu, A.(1995) Tissue culture techniques and chromosome preparation. In Human chromosomes principles and techniques 2nd ed. (pp. 6-71). New York: Mc Graw-Hill, Inc.
6. Mitelman, F.(1995) ISCN: An international system for human cytogenetic nomenclature. Basel: S Karger.
7. Ibrahim, NK. (2004) Leukemogenic effect of chemotherapy in patients with breast carcinoma Cancer, 101, pp. 1479-1481.
8. Weldon, CB and Jaffe, BM and Kahn, MJ. (2002) Therapy-induced leukemias and myledysplastic syndromes after breast cancer treatment: An underemphasized clinical problem Ann Surg Oncol, 9, pp. 738-744.
9. Praga, C and Bergh, J and Bliss, J and Bonneterre, J and Cesana, B and Coombes, RC and Fargeot, P and Folin, A and Fumoleau, P and Giuliani, R and Kerbrat, P and Hery, M and Nilsson, J and Onida, F and Piccart, M and Shepherd, L and Therasse, P and Wils, J and Rogers, D. (2005) Risk of acute myeloid leukemia and myelodysplastic syndrome in trials of adjuvant epirubicin for early breast cancer: Correlation with doses of epirubicin and cyclophosphamide J Clin Oncol, 23, pp. 4179-4191.
10. Park, MJ and Park, YH and Ahn, HJ and Choi, W and Paik, KH and Kim, JM and Chang, YH and Ryoo, BY and Yang, SH. (2005) Secondary hematological malignancies after breast cancer chemotherapy Leukemia Lymphoma, 46, pp. 1183-1188.
11. Smith, RE and Bryant, J and DeCillis, A and Anderson, S. (2003) Acute myeloid leukemia and myelodysplastic syndrome after doxorubicin-cyclophosphamide adjuvant therapy for operable breast cancer: The national surgical adjuvant breast and bowel project experience J Clin Oncol, 21, pp. 1195-1204.
12. Crump, M and Tu, D and Shepherd, L and Levine, M and Bramwell, V and Pritchard, K. (2003) Risk of acute leukemia following epirubicin-based adjuvant chemotherapy: A report from the National Cancer Institute of Canada clinical trials group J Clin Oncol, 21, pp. 3066-3071.